메뉴 건너뛰기




Volumn 62, Issue SUPPL. 3, 2005, Pages

Clinical and investigational considerations for the use of IGIV therapy

Author keywords

Concentration; Contamination; Control, quality; Drug use; Excipients; Formulations; Globulin immune; Injections; Manufacturing; Mechanism of action; Osmolarity; Serums; Sodium chloride; Stabilizers; Sugars; Toxicity; Volume

Indexed keywords

COMPLEMENT; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

EID: 23844475792     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050283     Document Type: Conference Paper
Times cited : (36)

References (46)
  • 1
    • 0035818044 scopus 로고    scopus 로고
    • Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
    • Kazatchkine MD, Kaveri S. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 2001; 345:747-55.
    • (2001) N Engl J Med , vol.345 , pp. 747-755
    • Kazatchkine, M.D.1    Kaveri, S.2
  • 2
    • 0032124204 scopus 로고    scopus 로고
    • Self-reactive antibodies (natural autoantibodies) in healthy individuals
    • Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998; 216:117-37.
    • (1998) J Immunol Methods , vol.216 , pp. 117-137
    • Lacroix-Desmazes, S.1    Kaveri, S.V.2    Mouthon, L.3
  • 3
    • 0032707209 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
    • Dalakas MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve. 1999; 22:1479-97.
    • (1999) Muscle Nerve , vol.22 , pp. 1479-1497
    • Dalakas, M.C.1
  • 4
    • 0015514084 scopus 로고
    • Giardiasis with malabsorption in X-linked agammaglobulinemia
    • Ochs HD, Ament ME, Davis SD. Giardiasis with malabsorption in X-linked agammaglobulinemia. N Engl J Med. 1972; 287:341-2.
    • (1972) N Engl J Med , vol.287 , pp. 341-342
    • Ochs, H.D.1    Ament, M.E.2    Davis, S.D.3
  • 6
    • 0022483563 scopus 로고
    • Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia
    • Roifman CM, Rao CP, Lederman HM et al. Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinemia. Am J Med. 1986; 80:590-4.
    • (1986) Am J Med , vol.80 , pp. 590-594
    • Roifman, C.M.1    Rao, C.P.2    Lederman, H.M.3
  • 7
    • 0032976666 scopus 로고    scopus 로고
    • Common variable immunodeficiency: Clinical and immunological features of 248 patients
    • Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999; 92:34-48.
    • (1999) Clin Immunol , vol.92 , pp. 34-48
    • Cunningham-Rundles, C.1    Bodian, C.2
  • 8
    • 0023237564 scopus 로고
    • High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease
    • Roifman CM, Levinson H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinemia and chronic lung disease. Lancet. 1987; 1:1075-7.
    • (1987) Lancet , vol.1 , pp. 1075-1077
    • Roifman, C.M.1    Levinson, H.2    Gelfand, E.W.3
  • 9
    • 0033511446 scopus 로고    scopus 로고
    • Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients
    • Quartier P, Debre M, De Blic J et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr. 1999; 134:589-96.
    • (1999) J Pediatr , vol.134 , pp. 589-596
    • Quartier, P.1    Debre, M.2    De Blic, J.3
  • 10
    • 0035822661 scopus 로고    scopus 로고
    • The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia
    • Eijkhout HW, van der Meer JWM, Kallenberg CGM et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann Intern Med. 2001; 135:165-74.
    • (2001) Ann Intern Med , vol.135 , pp. 165-174
    • Eijkhout, H.W.1    Van Der Meer, J.W.M.2    Kallenberg, C.G.M.3
  • 11
    • 0026001744 scopus 로고
    • Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy
    • Chapel H, Griffiths H, Brennan V et al. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy. Immunol Invest. 1991; 20:187-91.
    • (1991) Immunol Invest , vol.20 , pp. 187-191
    • Chapel, H.1    Griffiths, H.2    Brennan, V.3
  • 12
    • 0026715164 scopus 로고
    • Predictors of infection in chronic lymphocytic leukaemia (CLL)
    • Griffiths H, Lea J, Bunch C et al. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol. 1992; 89:374-7.
    • (1992) Clin Exp Immunol , vol.89 , pp. 374-377
    • Griffiths, H.1    Lea, J.2    Bunch, C.3
  • 13
    • 0028133629 scopus 로고
    • The use of intravenous immune globulin in multiple myeloma
    • Chapel HM, Lee M. The use of intravenous immune globulin in multiple myeloma. Clin Exp Immunol. 1994; 97(Suppl 1):21-4.
    • (1994) Clin Exp Immunol , vol.97 , Issue.SUPPL. 1 , pp. 21-24
    • Chapel, H.M.1    Lee, M.2
  • 14
    • 0028901880 scopus 로고
    • Immunological factors and risk of infection in plateau phase myeloma
    • Hargreaves RM, Lea JR, Griffiths H et al. Immunological factors and risk of infection in plateau phase myeloma. J Clin Pathol. 1995; 48:260-6.
    • (1995) J Clin Pathol , vol.48 , pp. 260-266
    • Hargreaves, R.M.1    Lea, J.R.2    Griffiths, H.3
  • 15
    • 0030321441 scopus 로고    scopus 로고
    • Prophylaxis against infections with low-dose intravenous immunoglobulins (FVIG) in chronic lymphocytic leukemia. Results of a crossover study
    • Molica S, Musto P, Chiurazzi F et al. Prophylaxis against infections with low-dose intravenous immunoglobulins (FVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica. 1996; 81:121-6.
    • (1996) Haematologica , vol.81 , pp. 121-126
    • Molica, S.1    Musto, P.2    Chiurazzi, F.3
  • 16
    • 0029019914 scopus 로고
    • Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients
    • Crow ME. Intravenous immune globulin for prevention of bacterial infections in pediatric AIDS patients. Am J Health-Syst Pharm. 1995; 52:803-11.
    • (1995) Am J Health-Syst Pharm , vol.52 , pp. 803-811
    • Crow, M.E.1
  • 17
    • 0031204924 scopus 로고    scopus 로고
    • Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection
    • Olopoenia L, Young M, White D et al. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection. J Natl Med Assoc. 1997; 89:543-7.
    • (1997) J Natl Med Assoc , vol.89 , pp. 543-547
    • Olopoenia, L.1    Young, M.2    White, D.3
  • 18
    • 0023622087 scopus 로고
    • Immunoglobulin therapy in bone marrow transplantation
    • Sullivan KM. Immunoglobulin therapy in bone marrow transplantation. Am J Med. 1987; 83:34-45.
    • (1987) Am J Med , vol.83 , pp. 34-45
    • Sullivan, K.M.1
  • 19
    • 0025102027 scopus 로고
    • Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation
    • Sullivan KM, Kopecky KJ, Jocom J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 1990; 323:705-12.
    • (1990) N Engl J Med , vol.323 , pp. 705-712
    • Sullivan, K.M.1    Kopecky, K.J.2    Jocom, J.3
  • 20
    • 0019463420 scopus 로고
    • High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
    • Imbach P, Barandun S, d'Apuzzo V et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1(8232):1228-31.
    • (1981) Lancet , vol.1 , Issue.8232 , pp. 1228-1231
    • Imbach, P.1    Barandun, S.2    D'Apuzzo, V.3
  • 21
    • 8944225498 scopus 로고    scopus 로고
    • Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
    • George JN, Woolf SH, Raskob GE et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:36-40.
    • (1996) Blood , vol.88 , pp. 36-40
    • George, J.N.1    Woolf, S.H.2    Raskob, G.E.3
  • 22
    • 0030907223 scopus 로고    scopus 로고
    • Experience with IVIg in the treatment of patients with myasthenia gravis
    • Dalakas MC. Experience with IVIg in the treatment of patients with myasthenia gravis. Neurology. 1997; 48(Suppl 1):64-9.
    • (1997) Neurology , vol.48 , Issue.SUPPL. 1 , pp. 64-69
    • Dalakas, M.C.1
  • 23
    • 0031034253 scopus 로고    scopus 로고
    • Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome
    • Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 1997; 349:225-30.
    • (1997) Lancet , vol.349 , pp. 225-230
  • 24
    • 0029128453 scopus 로고
    • Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin
    • Choudhary PP, Hughes RAC. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Q J Med. 1995; 88:493-502.
    • (1995) Q J Med , vol.88 , pp. 493-502
    • Choudhary, P.P.1    Hughes, R.A.C.2
  • 25
    • 0032423145 scopus 로고    scopus 로고
    • Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin
    • Hahn AF. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology. 1998; 51:16-21.
    • (1998) Neurology , vol.51 , pp. 16-21
    • Hahn, A.F.1
  • 26
    • 84860981816 scopus 로고    scopus 로고
    • Cells involved in immune responses
    • Hunt R.
    • Bowers W. Cells involved in immune responses. In: Hunt R. Microbiology and Immunology On-Line. http://www.med. sc.edu:85/bowers/immune%20cells.htm. Accessed 2005 May 26.
    • Microbiology and Immunology On-Line
    • Bowers, W.1
  • 27
    • 0034769492 scopus 로고    scopus 로고
    • Antibody-directed therapy: Past, present, and future
    • Gelfand EW. Antibody-directed therapy: past, present, and future. J Allergy Clin Immunol. 2001; 108(4 Suppl):S111-6.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.4 SUPPL.
    • Gelfand, E.W.1
  • 28
    • 0030929805 scopus 로고    scopus 로고
    • Fc receptor biology
    • Daëron M. Fc receptor biology. Annu Rev Immunol. 1997; 15:203-34.
    • (1997) Annu Rev Immunol , vol.15 , pp. 203-234
    • Daëron, M.1
  • 29
    • 0022644378 scopus 로고
    • Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody
    • Clarkson SB, Bussel JB, Kimberly RP et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med. 1986; 314:1236-9.
    • (1986) N Engl J Med , vol.314 , pp. 1236-1239
    • Clarkson, S.B.1    Bussel, J.B.2    Kimberly, R.P.3
  • 30
    • 0027504398 scopus 로고
    • Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura
    • Debré M, Bonnet MC, Fridman WH et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet. 1993; 342:945-9.
    • (1993) Lancet , vol.342 , pp. 945-949
    • Debré, M.1    Bonnet, M.C.2    Fridman, W.H.3
  • 31
    • 0035910392 scopus 로고    scopus 로고
    • Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
    • Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001; 291:484-6.
    • (2001) Science , vol.291 , pp. 484-486
    • Samuelsson, A.1    Towers, T.L.2    Ravetch, J.V.3
  • 32
    • 0030892121 scopus 로고    scopus 로고
    • Intravenous immune globulin therapy for neurologic diseases
    • Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997; 126:721-30.
    • (1997) Ann Intern Med , vol.126 , pp. 721-730
    • Dalakas, M.C.1
  • 33
    • 0022485186 scopus 로고
    • The treatment of Kawasaki syndrome with intravenous gamma globulin
    • Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986; 315:341-7.
    • (1986) N Engl J Med , vol.315 , pp. 341-347
    • Newburger, J.W.1    Takahashi, M.2    Burns, J.C.3
  • 34
    • 0032924155 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study
    • The Canadian Streptococcal Study Group
    • Kaul R, McGeer A, Norrby-Teglund A et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999; 28:800-7.
    • (1999) Clin Infect Dis , vol.28 , pp. 800-807
    • Kaul, R.1    McGeer, A.2    Norrby-Teglund, A.3
  • 35
    • 0036226952 scopus 로고    scopus 로고
    • Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders
    • Larroche C, Chanseaud Y, Garcia de la Pena-Lefebvre P et al. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders. Biodrugs. 2002; 15:47-55.
    • (2002) Biodrugs , vol.15 , pp. 47-55
    • Larroche, C.1    Chanseaud, Y.2    Garcia De La Pena-Lefebvre, P.3
  • 36
    • 0024314008 scopus 로고
    • Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
    • Leung DY, Cotran RS, Kurt-Jones E et al. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. 1989; 2:1298-1302.
    • (1989) Lancet , vol.2 , pp. 1298-1302
    • Leung, D.Y.1    Cotran, R.S.2    Kurt-Jones, E.3
  • 37
    • 0032588204 scopus 로고    scopus 로고
    • I.V. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome
    • Sharief MK, Ingram DA, Swash M et al. I.V. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome. Neurology. 1999; 52:1833-8.
    • (1999) Neurology , vol.52 , pp. 1833-1838
    • Sharief, M.K.1    Ingram, D.A.2    Swash, M.3
  • 38
    • 0028113940 scopus 로고
    • High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
    • Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest. 1994; 94:1729-35.
    • (1994) J Clin Invest , vol.94 , pp. 1729-1735
    • Basta, M.1    Dalakas, M.C.2
  • 39
    • 0029920575 scopus 로고    scopus 로고
    • Kawasaki syndrome: Immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin
    • Leung DY. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin. Clin Exp Immunol. 1996; 104(Suppl 1):49-54.
    • (1996) Clin Exp Immunol , vol.104 , Issue.SUPPL. 1 , pp. 49-54
    • Leung, D.Y.1
  • 40
    • 0034775211 scopus 로고    scopus 로고
    • Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses
    • Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol. 2001; 108(4 Suppl):S107-10.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.4 SUPPL.
    • Schlievert, P.M.1
  • 41
    • 0021221197 scopus 로고
    • Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin
    • Sultan Y, Kazatchkine MD, Maisonneuve P et al. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984; 2:765-8.
    • (1984) Lancet , vol.2 , pp. 765-768
    • Sultan, Y.1    Kazatchkine, M.D.2    Maisonneuve, P.3
  • 42
    • 0026684691 scopus 로고
    • Can intravenous immunoglobulin treatment regulate autoimmune responses?
    • Kaveri SV, Dietrich G, Kazatchkine MD. Can intravenous immunoglobulin treatment regulate autoimmune responses? Semin Hematol. 1992; 29(3 Suppl 2):64-71.
    • (1992) Semin Hematol , vol.29 , Issue.3 SUPPL. 2 , pp. 64-71
    • Kaveri, S.V.1    Dietrich, G.2    Kazatchkine, M.D.3
  • 43
    • 0025254342 scopus 로고
    • Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies
    • Dietrich G, Kazatchkine MD. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest. 1990; 85:620-5.
    • (1990) J Clin Invest , vol.85 , pp. 620-625
    • Dietrich, G.1    Kazatchkine, M.D.2
  • 44
    • 0033590571 scopus 로고    scopus 로고
    • Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
    • Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999; 340:227-8.
    • (1999) N Engl J Med , vol.340 , pp. 227-228
    • Yu, Z.1    Lennon, V.A.2
  • 45
    • 23844462835 scopus 로고    scopus 로고
    • Pharmacy considerations for the use of IGIV therapy
    • Shah S. Pharmacy considerations for the use of IGIV therapy. Am J Health-Syst Pharm. 2005; 62(Suppl 3):S5-11.
    • (2005) Am J Health-Syst Pharm , vol.62 , Issue.SUPPL. 3
    • Shah, S.1
  • 46
    • 0032538505 scopus 로고    scopus 로고
    • Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
    • Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998; 282:490-3.
    • (1998) Science , vol.282 , pp. 490-493
    • Viard, I.1    Wehrli, P.2    Bullani, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.